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Cyp26 enzymes generate the retinoic acid response pattern
necessary for hindbrain development
Rafael E. Hernandez1,2,*, Aaron P. Putzke1,*, Jonathan P. Myers1,†, Lilyana Margaretha1 and Cecilia B. Moens1,‡
Retinoic acid (RA) is essential for normal vertebrate development, including the patterning of the central nervous system. During
early embryogenesis, RA is produced in the trunk mesoderm through the metabolism of vitamin A derived from the maternal diet
and behaves as a morphogen in the developing hindbrain where it specifies nested domains of Hox gene expression. The loss of
endogenous sources of RA can be rescued by treatment with a uniform concentration of exogenous RA, indicating that domains of
RA responsiveness can be shaped by mechanisms other than the simple diffusion of RA from a localized posterior source. Here, we
show that the cytochrome p450 enzymes of the Cyp26 class, which metabolize RA into polar derivatives, function redundantly to
shape RA-dependent gene-expression domains during hindbrain development. In zebrafish embryos depleted of the orthologs of
the three mammalian CYP26 genes CYP26A1, CYP26B1 and CYP26C1, the entire hindbrain expresses RA-responsive genes that are
normally restricted to nested domains in the posterior hindbrain. Furthermore, we show that Cyp26 enzymes are essential for
exogenous RA to rescue hindbrain patterning in RA-depleted embryos. We present a ‘gradient-free’ model for hindbrain
patterning in which differential RA responsiveness along the hindbrain anterior-posterior axis is shaped primarily by the dynamic
expression of RA-degrading enzymes.

INTRODUCTION
Retinoic acid (RA) is a known teratogen with crucial roles in the
patterning of the vertebrate nervous system. In the hindbrain, RA is
essential for the establishment of the anterior-posterior pattern, as
demonstrated by embryos in which RA is depleted either dietarily,
pharmacologically or genetically (Begemann et al., 2004; Dupe and
Lumsden, 2001; Maden et al., 1996; Niederreither et al., 1999). RA
is produced in the anterior paraxial mesoderm by the activity of
aldehyde dehydrogenase 1 family, member A2 (Aldh1a2), which
oxidizes retinal to RA (Begemann et al., 2001; Gavalas, 2002;
Niederreither et al., 1999). RA either diffuses or is transported from
the paraxial mesoderm into the adjacent central nervous system. RA
directly regulates gene expression through its nuclear hormone
receptor (RAR) and co-receptor (RXR), which bind RA response
elements (RAREs) in the enhancers of target genes (Bastien and
Rochette-Egly, 2004). In the hindbrain, RA regulates the expression
of 3⬘-Hox genes through direct (in the case of Hox-1 and Hox-4
genes) or indirect (in the case of Hox-3 genes) mechanisms (Gould
et al., 1998; Hernandez et al., 2004; Marshall et al., 1994; Nolte et
al., 2003; Studer et al., 1994; Zhang et al., 2000). Other anterior RAresponsive genes (Hox-1 family genes) are expressed earlier and at
lower RA concentrations than the more-posterior RA-responsive
genes (Hox-4 family genes) (Dupe and Lumsden, 2001; Maves and
Kimmel, 2005; Simeone et al., 1990). Based on the effects of
switching the RAREs of the Hox-1 and Hox-4 genes, Gould et al.
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proposed that Hox-1 genes are expressed at more anterior levels than
Hox-4 genes because their RAREs are more sensitive to RA (Gould
et al., 1998).
These data have lead to a model in which a continuous spatiotemporal gradient of RA through the hindbrain generates nested
domains of RA-responsive gene expression. These domains are then
resolved by secondary mechanisms into non-overlapping domains
that correspond with the morphological segments of the hindbrain –
the rhombomeres (r). However, a number of observations suggest
that an RA gradient is neither detectable nor required for normal
hindbrain development. First and foremost, embryos depleted of
endogenous RA can be fully rescued by a uniform concentration of
exogenous RA (Begemann et al., 2004; Begemann et al., 2001; Gale
et al., 1999; Grandel et al., 2002; Mic et al., 2002; Niederreither et
al., 2000). Second, this rescue can be accomplished by a range of RA
concentrations and over a range of developmental stages (Dupe and
Lumsden, 2001; Maves and Kimmel, 2005). Third, when RA
responsiveness is measured by the expression of a RARE-LacZ
reporter, no gradient of expression is detected in the hindbrain.
Instead, distinct boundaries of reporter expression that shift over
time are detected (Rossant et al., 1991; Sirbu et al., 2005). Finally,
in contrast to earlier findings (Gould et al., 1998), recent evidence
has suggested that, in the context of their intact enhancers, a Hox-1
RARE is equally responsive to RA as a Hox-4 RARE (Nolte et al.,
2003).
These data suggest that cells in the presumptive hindbrain
neuroepithelium can be patterned by RA in a manner that is
independent both of concentration and of duration of exposure,
necessitating a new model for RA-dependent hindbrain patterning.
Here, we propose such a model based on the hindbrain patterning
defects caused by the prevention of RA metabolism by the
cytochrome P450 enzymes of the Cyp26 class. The Cyp26 enzymes
(Cyp26a1, Cyp26b1 and Cyp26c1) have been proposed to function
in the regulation of RA-dependent gene expression through their
ability to metabolize RA into hydroxylated polar derivatives (Fujii
et al., 1997; White et al., 1996). In the mouse tailbud and limbs, loss
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of Cyp26 function leads to increased RA-dependent gene
expression, spina bifida and caudal agenesis similar to the
teratogenic effects of high concentrations of exogenous RA (AbuAbed et al., 2001; Sakai et al., 2001; Yashiro et al., 2004).
With regard to hindbrain patterning, cyp26a1 is expressed during
gastrulation in the anterior neurectoderm (Dobbs-McAuliffe et al.,
2004; Kudoh et al., 2002). Based on this expression domain, it was
hypothesized that localized regions of RA synthesis in the anterior
trunk mesoderm and degradation in the anterior neural plate provide
a classical ‘source-and-sink’ mechanism for the spatial regulation of
RA in the central nervous system (Kudoh et al., 2002; Swindell et al.,
1999). However, cyp26a1 mutants in fish and mouse exhibit relatively
subtle hindbrain-patterning defects inconsistent with a global role for
cyp26a1 in hindbrain patterning (Abu-Abed et al., 2001; Emoto et al.,
2005; Kudoh et al., 2002; Sakai et al., 2001). The recent identification
of other cyp26 genes has suggested that these may participate in
shaping RA responsiveness in the hindbrain (Abu-Abed et al., 2002;
Gu et al., 2005; MacLean et al., 2001; Reijntjes et al., 2005; Reijntjes
et al., 2004; Sirbu et al., 2005; Tahayato et al., 2003; Taimi et al., 2004;
Zhao et al., 2005). Here, we demonstrate that the zebrafish orthologs
of mammalian CYP26B1 and CYP26C1 function redundantly with
cyp26a1 to pattern the hindbrain, because embryos depleted of all
three proteins exhibit a profound posterior transformation of the
hindbrain. Furthermore, we demonstrate that cyp26 genes are
responsible for the ability of exogenous RA to rescue embryos
depleted of endogenous sources of RA. In embryos depleted of Cyp26
activity, the low RA concentrations that normally rescue the RAdepleted hindbrain are highly teratogenic. Based on our results, we
present a ‘gradient-free’ model for RA-dependent hindbrain patterning
in which the spatially regulated inactivation of RA by Cyp26 enzymes
is responsible for the establishment of RA-responsive gene-expression
domains in the hindbrain.
MATERIALS AND METHODS
Cloning

Cyp26b1 was initially identified as an EST (Nelson, 1999), and we cloned
the 5⬘ end of the coding sequence with the SMART RACE kit (Clontech).
cyp26c1 was identified in a Blast search of the zebrafish genome sequence
using the human CYP26C1 protein sequence and was then amplified from
12 hour post fertilization (hpf) whole-zebrafish-embryo cDNA.
Morpholinos, RNA in situ hybridizations and genotyping

Table 1 summarizes the sequences of the morpholinos (MOs) used in this
study, the combinatorial depletion experiments performed and their
outcomes. To determine the efficacy of cyp26b1 MO1, we made a
cyp26b1-GFP fusion construct by cloning a fragment of the 5⬘ UTR and

5⬘ coding sequence including the MO target sequence into pCS2GFPLTXLT. The resulting plasmid was linearized with NotI and mRNA
was prepared for injection with the SP6 mMessage mMachine kit
(Ambion). Embryos were injected with 470 pg mRNA plus 5 ng MO.
Embryo lysates were prepared as described (Waskiewicz et al., 2001),
separated on 4-12% NuPAGE Bis-Tris gels and transferred to Invitrolon
PVDF membranes (Invitrogen). For immunoblotting, we used anti-GFP
(Torrey Pines, 1:2000) and anti-Actin (SantaCruz, sc1616, 1:200), and
proteins were detected with SuperSignal West Dura substrate (Pierce)
according to the manufacturer’s directions. Quantitation of the GFP bands
showed that cyp26b1 MO blocked 95-98% of the translation of the injected
cyp26b1-GFP mRNA.
We used RT-PCR to determine the efficacy of cyp26c1 MO1, which is
targeted to the exon-3–intron-3 splice junction of the pre-mRNA. RT-PCR
analysis with multiple primer pairs revealed no detectable wild-type
transcript. Three alternately spliced transcripts were detected and sequenced:
two resulted in the introduction of a premature stop codon either by the
inclusion of intron 3 or the exclusion of exon 3. A third transcript resulted in
the deletion of the last 18 bases of exon 3, which leaves the transcript in
frame but deletes six amino acids, several of which are conserved across
Cyp26 family members.
All of the experiments described in this manuscript used cyp26b1 MO1
and cyp26c1 MO1; however, cyp26b1 MO2 and cyp26c1 MO2 gave the
same phenotypes. Unlike cyp26c1 MO1, cyp26c1 MO2 was toxic at higher
concentrations. Our control MO was targeted to the dead-end mRNA and
eliminates primordial germ cells but does not affect other aspects of
development (Weidinger et al., 2003). To assay for redundancy between the
cyp26 genes, MOs were injected alone or in combination into embryos from
a cyp26a1+/– intercross (Emoto et al., 2005). In order to control for nonspecific effects due to MO injections, all embryos were injected with a total
of 5 ng MO as determined by measuring the diameter of the injected bolus
in mineral oil (see Table 1).
Two-color RNA in situ hybridizations were performed, essentially as
described (Prince et al., 1998), except that Iodo-Nitrotetrazolium Violet
(Sigma) was used as the red Alkaline Phosphatase substrate. Embryos were
de-yolked and flat-mounted for photomicroscopy using a Zeiss Axioplan II
microscope. After photographing, individual embryos were un-mounted and
genotyped for the cyp26a1 mutation as described (Emoto et al., 2005).
Drug treatments

Dechorionated embryos from wild-type or cyp26a1+/– parents were
incubated in the dark in pharmacological agonists and antagonists of the RAmetabolism pathway as follows:
4-(diethylamino)benzaldehyde [DEAB, an inhibitor of retinaldehyde
dehydrogenases (Russo et al., 1988); Aldrich]: 10 M, beginning at 50%
epiboly [5.25 hpf (Kimmel et al., 1995)];
R115866, a specific inhibitor of Cyp26 enzymes (Janssen Pharmaceutica):
10 M, beginning at dome stage (4.33 hpf);
all-trans RA (Sigma): 0.1-100 nM, beginning at 50% epiboly.

Table 1. Summary of combinatorial cyp26 knock-down experiments and their outcomes
Summary of phenotype

5 ng control MO
2.5 ng cyp25b1 MO1 + 2.5 ng control MO
2.5 ng cyp25c1 MO1 + 2.5 ng control MO
2.5 ng cyp25b1 MO1 + 2.5 ng cyp26c1 MO
5 nM RA
10 M DEAB + 5 nM RA

Cyp26a1+

None
None
None
None
None
None

Cyp26a1–/–

Very mild (expanded r4)
Very mild (expanded r4)
Medium (up to cerebellum)
Severe (up to cerebellum)
Severe (throughout brain)
Severe (throughout brain)

Morpholino sequences:

Cyp26b1 MO1 (ATG)
Cyp26b1 MO2 (exon-2–intron-2 splice)
Cyp26c1 MO1 (exon-3–intron-3 splice)
Cyp26c1 MO2 (intron-1–exon-2 splice)
Control (dead-end MO)

5⬘-CTCGAAGAGCATGGCTGTGAACGTC-3⬘
5⬘-ATTGACCTTACCTTCCTCCTTTTGC-3⬘
5⬘-AAACTCGGTTATCCTCACCTTGCGC-3⬘
5⬘ GGAACCCTGTCACAACATAACAGAG-3⬘
5⬘-GCTGGGCATCCATGTCTCCGACCAT-3⬘
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In each case, the compound was diluted to 1000 times its final
concentration in DMSO and then diluted 1000-fold in embryo medium.
Controls were treated with carrier alone (0.1% DMSO). For retinal
treatments, embryos were injected at the one-cell stage with 1 nl of 20
pmol/nl all-trans retinal in DMSO (Sigma), and controls were injected with
1 nl DMSO alone.

RESULTS
cyp26b1 and cyp26c1 are expressed dynamically
during hindbrain development
Mammalian genomes contain three CYP26 genes: CYP26A1,
CYP26B1 and CYP26C1. Cloning of the zebrafish cyp26a1 ortholog
has been described (White et al., 1996). We cloned zebrafish
homologs of cyp26b1 and cyp26c1, and examined their expression
during development. Cyp26c1 has been previously described as

cyp26d1 (Gu et al., 2005) and cyp26b1-like (Kawakami et al., 2005)
(ZDB gene 050714-2). Based on two lines of evidence, we argue that
this gene is in fact the ortholog of mammalian CYP26C1. First,
phylogenetic analysis of zebrafish cyp26 genes places it in the same
clade as mouse and human CYP26C1 genes with moderate bootstrap
support (see Fig. S1A in the supplementary material). Second,
CYP26A1 and CYP26C1 are adjacent to one another on human
chromosome 10q23-q24, and current zebrafish genomic sequence
data and radiation-hybrid data places zebrafish cyp26a1 and cyp26c1,
cyp26d1- and cyp26b1-like in regions of zebrafish linkage groups
(LGs) 12 and 17, respectively, which show synteny to human
chromosome 10 (see Fig. S1B in the supplementary material) (Woods
et al., 2005). Because draft genomes for other tetrapod vertebrates also
show CYP26A1 and CYP26C1 as adjacent genes, it is likely that they
were adjacent genes in the ancestral vertebrate genome and that,
following the proposed genome duplication early in teleost evolution,
the duplicate of cyp26c1 was lost from LG 12 and the duplicate of
cyp26a1 was lost from LG 17. Henceforth, we refer to the gene
previously named cyp26d1 or cyp26b1-like as cyp26c1.
The expression patterns of zebrafish cyp26a1, cyp26b1 and
cyp26c1 have been described (Dobbs-McAuliffe et al., 2004; Gu et
al., 2005; Kudoh et al., 2002; Zhao et al., 2005). We focus here on
their expression during hindbrain development. During gastrulation,
cyp26a1 is expressed in the anterior neurectoderm (bracket in Fig.
1B) and in a narrow domain at the margin at 8.5 hpf (arrowhead in
Fig. 1B). The posterior limit of cyp26a1 expression at 8.5 hpf abuts
the anterior limit of hoxb1b expression at the r3-r4 boundary (Kudoh
et al., 2002), but rapidly recedes anteriorly to lie at the r2-r3
boundary at 10 hpf and lies further anterior still at 11 hpf (Fig. 1F,G).
As described previously, cyp26a1 is directly RA-inducible, even at
sub-teratogenic concentrations of RA (5 nM), which cause the
ectodermal domain of expression to expand towards the margin (Fig.
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Fig. 1. Expression of the cyp26 genes in the developing
hindbrain. (A-R) Whole-mount in situ hybridizations during the
hindbrain patterning period. All embryos are shown as dorsal views.
Anterior is to the top in A-I and to the left in J-R. In situ probes are
noted in brackets beside the panels, embryonic age is noted in hours
post fertilization (hpf). (A) Schematic of an 80% epiboly (8.5 hpf)
embryo. The dotted box is the region shown in the flat-mounted
embryos in B-E; the arrowhead indicates the advancing margin of the
epiblast. During gastrulation, cyp26a1 (B-D,F,G) is expressed in the
ectoderm (bracket in B-D) anterior to the domain of RA synthesis
indicated by aldh1a2 expression (bracket in E). (C,D) Ectodermal
cyp26a1 expression expands in the presence of sub-teratogenic
concentrations of RA (C), but is established independent of RA (D). (F,G)
cyp26a1 expression recedes anteriorly at the onset of somitogenesis.
krox20 (red) is shown in r3 and r5. Arrowhead indicates the posterior
limit of cyp26a1 expression. Bracket marks weak cyp26a1expression in
the anterior trunk mesoderm. (H,I) aldh1a2 expression during early
somitogenesis. Bracket shows expression in trunk mesoderm. (J-R)
Dynamic cyp26b1 (J-M) and cyp26c1 (N-R) expression during
somitogenesis. krox20 expression in r3 and r5 is in red in J-P; cyp26b1
expression is shown in blue in J-M; and cyp26c1 expression is shown in
blue in N-R. In Q,R, cyp26c1 is in red whereas hoxd4 (Q) and vhnf1 (R)
are in blue. Insets in Q,R correspond to the dotted boxes. Dotted curve
in O indicates the cyp26c1-free domain in ventral r3-r6. Scale bars: 100
M. Scale bar in B is for B-E; scale bar in F is for F-I; scale bar in J is for
J,N,R; scale bar in K is for K,O; scale bar in L is for L,M,P. AN; anterior
neurectodermal expression; TB, tailbud expression.
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1C) (Dobbs-McAuliffe et al., 2004; Kudoh et al., 2002; Loudig et
al., 2000; White et al., 1996). In spite of its strong RA-inducibility,
the early anterior neurectodermal expression of cyp26a1 is
established independently of RA, evident because it is unaffected in

Fig. 2. cyp26b1 and cyp26c1 function redundantly with cyp26a1
to pattern the hindbrain. Whole-mount RNA in situ hybridizations
at 18 hpf (A-J) and 13 hpf (K,L) and immunostaining at 48 hpf (M,N)
in wild-type (left column) and cyp26a1–/– (right column) embryos
injected with MOs as shown on the left. (A-H) pax2a (blue) marks the
optic stalk (os), posterior midbrain and cerebellum (bracket), and the
otic vesicles (ov); whereas hoxd4 (also blue) marks the r7-r8 territory
and krox20 (red) marks r3 and r5. MO depletion of Cyp26b1 and/or
Cyp26c1 does not affect this pattern in wild-type embryos (C,E,G),
but progressively posteriorizes the hindbrain in cyp26a1–/– embryos
(D,F,H). Arrowhead marks the r6-r7 boundary, which is shifted to the
anterior hindbrain in Cyp26-depleted embryos. (I,J) en3 (red) marks
the posterior midbrain and cerebellum (bracket) and hoxb1a (blue)
marks r4, which is shifted anteriorly in Cyp26-depleted embryos. (K,L)
pax2a (blue) and krox20 (red) are expressed as described above.
vhnf1 (also blue) is expressed in the posterior hindbrain up to the r5r6 boundary (arrowheads) and is also shifted anteriorly in Cyp26depleted embryos. (M,N) The isl1-GFP transgene (green) marks cranial
motor neurons (nV: trigeminal motor neurons in r2 and r3; nVII: facial
motor neurons in r4-6; nX: vagal motor neurons in r8) whereas the
zn5 antibody (red) marks spinal motor neurons (arrows), pharyngeal
arch endoderm (pe, arrowheads mark individual pharyngeal arches)
and other structures. The large white arrowhead indicates the midhindbrain boundary. In Cyp26-depleted embryos, the motor neurons
of the vagus nerve (nX) are expanded anteriorly, as are the spinal
motor neurons. Scale bars: 100 m. Scale bar in A is for A-H,K,L;
scale bar in I is for I,J.
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embryos treated with 4-(diethylamino)benzaldehyde (DEAB), a
specific inhibitor of retinaldehyde dehydrogenase (Fig. 1D) (DobbsMcAuliffe et al., 2004; Sirbu et al., 2005). Throughout the
hindbrain-patterning period, neurectodermal cyp26a1 expression
lies significantly anterior to that of aldh1a2, which is restricted to
the anterior mesoderm (Fig. 1E,H,I) (Dobbs-McAuliffe et al., 2004;
Kudoh et al., 2002; Sirbu et al., 2005; Swindell et al., 1999). cyp26a1
is also expressed in the tailbud and in a crescent in the anterior trunk
mesoderm immediately anterior to the aldh1a2-expressing domain
(brackets in Fig. 1F,G).
cyp26b1 and cyp26c1 are expressed in the developing hindbrain
in a dynamic, rhombomere-restricted fashion. cyp26b1 expression
is initiated in r3 and r4 beginning at tailbud stage (10 hpf; Fig. 1J).
This expression slowly expands to include r2 by the 12-somite stage
(15 hpf; Fig. 1L), and r5 and r6 by the 20-somite stage (19 hpf; Fig.
1M). cyp26c1 expression overlaps with, but precedes, cyp26b1
expression at each stage. cyp26c1 expression is initiated earlier,
before the end of gastrulation (9 hpf), in presumptive r2 through r4
in a domain that abuts the anterior limit of vhnf1 (also known as tcf2
– Zebrafish Information Network; ZDB gene 020104-1) expression
at the presumptive r4-r5 boundary (Fig. 1N,R). Expression rapidly
expands posteriorly to include r6 by the 6-somite stage (12 hpf), at
which time the posterior limit of cyp26c1 expression abuts the
anterior limit of hoxd4 (also known as hoxd4a – Zebrafish
Information Network) expression (Fig. 1O,Q). At the same time,
cyp26c1 (but not cyp26b1) expression is downregulated in r3.
cyp26c1 (but not cyp26b1) expression is excluded from the ventralmost hindbrain above the anterior tip of the notochord during the
early somite stages (dotted line in Fig. 1). Although the significance
of this ventral exclusion of cyp26c1 expression for RA distribution
is not known, we find that the ventral hindbrain is more sensitive to
exogenous RA than are more dorsal hindbrain regions (see Fig. S2
in the supplementary material). By 14 hpf, cyp26c1 expression is
downregulated in r2 to r4 and is strongly up-regulated in r5 and r6
(Fig. 1P).
Unlike cyp26a1, neither cyp26b1 nor cyp26c1 are globally
upregulated by exogenous RA (data not shown, and see Fig. S3B,E
in the supplementary material). RA is also not required for the
normal onset of their expression, evident because both genes are
expressed in DEAB-treated embryos (see Fig. S3C,F in the
supplementary material). However, we did observe effects on the
expression of both cyp26b1 and cyp26c1 at the 3-somite stage that
suggest that both genes are affected indirectly by RA-dependent
patterning events in the hindbrain (see Fig. S3 in the supplementary
material). Briefly, in 100 nM RA, r4 is expanded anteriorly, and with
it the r4 expression of cyp26b1 and cyp26c1, whereas in 10 M
DEAB r2 and r3 are expanded posteriorly, and with them the r2 and
r3 expression of cyp26b1 and cyp26c1. Sirbu et al. (Sirbu et al.,
2005) showed that cyp26c1 expression in r4 is dependent upon RA.
We do not see clear evidence of this in the zebrafish, although the r4
domain of cyp26c1 expression is consistently reduced at the 3somite stage in DEAB-treated embryos (see Fig. S3B in the
supplementary material).
cyp26b1 and cyp26c1 contribute to normal
hindbrain patterning
We tested the function of Cyp26b1 and Cyp26c1 by knocking-down
their function using antisense MOs. We performed all of our
experiments in embryos generated by intercrossing cyp26a1
heterozygotes so that we could examine Cyp26b1 and Cyp26c1
function both in the presence and in the absence of Cyp26a1
function (Table 1). The hindbrain phenotype of cyp26a1 mutants is
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Fig. 3. A selective antagonist of Cyp26 enzymes recapitulates the
cyp26a1; cyp26b1; cyp26c1 phenotype. RNA in situ hybridizations
with the markers described in Fig. 2. (A-F) Compared with DMSOtreated controls (A,C,E), treatment with 10 M R115866 (B,D,F) causes
an anterior shift of hoxb1a (arrowhead in A,B) and hoxd4 (arrowhead
in C,D) towards the presumptive cerebellum, marked by en3 (red in
A,B) and by pax2a (brackets in C-F). This effect of R115866 is reversed
by co-treatment with 10 M DEAB (E,F). Scale bars: 100 m. Scale bar
in A is for A,B; Scale bar in C is for C-F.

subtle: r4 [marked by hoxb1a and bounded by the r3 and r5 stripes
of krox20 (also known as egr2b – Zebrafish Information Network)]
is slightly expanded in length and the anterior hindbrain (r1-r3) is
slightly reduced (Fig. 2A,B, Fig. 4A,B and see Fig. S4A,B in the
supplementary material) (Emoto et al., 2005). Furthermore, the
posterior-most hindbrain – marked by high levels of hoxd4
expression, and comprising r7 and the long unsegmented ‘vagal’
rhombomere, r8, which lies between the segmented hindbrain and
the first somite (Lumsden, 1990) – is expanded in length as
described previously (Emoto et al., 2005) (Fig. 2A,B and Fig. 4A,B).
Depleting embryos of either Cyp26b1 or Cyp26c1, or of both
enzymes, caused no brain-patterning phenotype in wild-type embryos,
aside from a subtle shortening of the hindbrain (Fig. 2 and see Fig. S4
in the supplementary material, left columns). However, depleting both
enzymes strongly enhanced the cyp26a1–/– hindbrain phenotype (Fig.
2 and see Fig. S4 in the supplementary material, right columns). In
cyp26b1 MO-injected cyp26a1–/– embryos, r4 is further expanded
(Fig. 2D and see Fig. S4C,D in the supplementary material) and the
r6-r7 boundary is shifted slightly towards r5 (arrowhead in Fig. 2C,D).
Knocking-down cyp26c1 caused a stronger enhancement of the
cyp26a1–/– phenotype, consistent with its earlier onset of expression
in the presumptive hindbrain. In these embryos, r3 is strongly reduced
or absent, whereas r4 is expanded anteriorly so that its anterior limit
lies adjacent the posterior limit of en3 (also known as eng2b –
Zebrafish Information Network) expression in the presumptive
cerebellum (Fig. 2F and see Fig. 4F in the supplementary material).
The r6-r7 boundary is again shifted anteriorly, but remains posterior
to a narrow r5 (arrowhead in Fig. 2F).
Embryos depleted of all three Cyp26 proteins have a strongly
posteriorized hindbrain (Fig. 2G-L and see Fig. S4G,H in the
supplementary material). Both r3 and r5 are eliminated (Fig. 2G,H)
and r4 abuts the cerebellum (Fig. 2I,J and see Fig. S4G,H in the
supplementary material). The anterior limit of vhnf1 expression,
which, by the 8-somite stage (13 hpf), marks the r5-r6 boundary, is
also shifted to abut the cerebellum (arrowheads in Fig. 2K,L). The
r6-r7 boundary of hoxd4 expression is similarly shifted, coming to
lie within a few cell diameters of cerebellum (arrowhead in Fig. 2H).
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Thus, three RA-responsive genes (hoxb1a, vhnf1 and hoxd4) that
normally form nested expression domains in the hindbrain are all
expanded into the anterior-most hindbrain in embryos depleted of
all three Cyp26 proteins. In spite of this strong transformation of the
hindbrain, the patterning of the mid- and fore-brain, marked by
pax2a, otx2, dlx2a and eomes, appears unaffected, except for a
decrease in length detectable in cyp26a1 single mutants (data not
shown) (Emoto et al., 2005).
We examined the neuronal organization of Cyp26-depleted
embryos. In cyp26a1+ embryos injected with control MOs or with
cyp26b1 and/or cyp26c1 MOs, we observed normal patterns of
cranial and spinal motor-nerve differentiation (Fig. 2M). However,
in cyp26a1–/– embryos injected with both cyp26b1 MO and cyp26c1
MO, the vagal neurons (nX in Fig. 2M,N) characteristic of r8 are
expanded to the mid-hindbrain boundary (large arrowhead in Fig.
2M,N) and spinal motor roots (arrows in Fig. 2M,N) extend from
hindbrain levels into a disorganized branchial region (small
arrowheads in Fig. 2M,N). This occurs in spite of the fact that there
are no somites to innervate at this level (data not shown). These
neuronal phenotypes are consistent with our analysis of marker gene
expression, in which the RA-inducible hox gene characteristic of r78 (hoxd4) is expanded anteriorly throughout the hindbrain region.
A pharmacological inhibitor of Cyp26 activity
phenocopies Cyp26 depletion
Pharmacological antagonists that inhibit RA metabolism have been
developed as tools for the treatment of dermatological diseases and
cancer (Njar, 2002; Njar et al., 2006). The compound R115866 is a
highly selective antagonist of Cyp26a1 activity in vitro, and exerts
retinoidal effects in adult rats (Stoppie et al., 2000). Its effects on
Cyp26b1 and Cyp26c1 have not been examined. We observed that
treating zebrafish embryos with 10 M R115866 caused a
phenotype identical to that of embryos depleted of all three Cyp26
enzymes (compare Fig. 2J,H with Fig. 3B,D). This suggests that
R115866 inhibits Cyp26b1 and Cyp26c1 as effectively as does
knocking-down their expression with MOs, and confirms our above
observation that Cyp26 activity is essential for normal hindbrain
patterning. The effects of R115866 treatment are completely
reversed by the addition of DEAB, so that embryos treated with both
drugs resemble embryos treated with DEAB alone (Fig. 3E,F). This
demonstrates that, as for other phenotypes observed in cyp26a1mutant fish and mice (Emoto et al., 2005; Niederreither et al., 2002),
the posteriorized hindbrain phenotype caused by blocking all Cyp26
activity is due to the accumulation of excess RA and not to the
absence of bioactive Cyp26-generated RA derivatives. Although
such derivatives have been observed to have significant retinoidal
effects in cells and in embryos, and have been postulated to have
functions in vivo (Idres et al., 2002; Pijnappel et al., 1993), we see
no evidence for their having a role in hindbrain patterning.
Cyp26a1 protects against RA teratogenicity.
The long-standing observation that depletion of endogenous RA can
be rescued by treatment with a low concentration of exogenous RA
demonstrates that a RA gradient is not strictly necessary for
hindbrain patterning (Begemann et al., 2004; Begemann et al., 2001;
Gale et al., 1999; Niederreither et al., 2000). However, the basis of
this rescue phenomenon has not been determined, and has
significant implications for the mechanism of hindbrain patterning.
We hypothesized that Cyp26 enzymes enable this rescue by
inactivating exogenous RA in a patterned manner. We tested the
roles of the cyp26 genes by performing the RA-rescue experiment
in Cyp26-depleted embryos.
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Fig. 4. cyp26a1 protects the hindbrain from
exogenous RA. Wild-type (left column) and
cyp26a1–/– (right column) embryos treated with
DMSO (A,B), 10 M DEAB (C,D) or 10 M DEAB + 5
nM RA (E-L). RNA in situ hybridizations use the
markers described in Fig. 2, except for I,J, which is a
mix of en3 (bracket), krox20 (r3, r5), dlx2 [cranial
neural crest (cnc) and forebrain (fb)] and myoD
(somites; s). Large bracket in A indicates the r7-r8
region, which is elongated in cyp26a1 mutants (B).
(C) In DEAB-treated embryos, posterior
rhombomeres (r5-r8) are absent (arrow indicates the
absence of high hoxd4 expression characteristic of
r7-r8). (D) This phenotype is partially rescued in
cyp26a1 mutants, as seen by rescue of r5 but not of
r7-r8. (E-L) The DEAB phenotype is fully rescued in
wild-type embryos by treatment with 5 nM RA
(E,G,I,K) whereas, in cyp26a1 mutants, this low dose
of RA causes strong posteriorization of the brain
(F,H,J,L). This phenotype resembles that of wild-type
embryos treated with 200 nM RA (inset in J). Scale
bar: 100 m. os: optic stalk; e: eye; p: pronephros.

We asked why, under normal circumstances, cyp26b1 and
cyp26c1 can compensate for a lack of cyp26a1 (Fig. 2), whereas, in
the presence of 5 nM RA, they cannot (Fig. 4). A total of 5 nM RA
is sufficient to induce expression of cyp26a1 far posterior to its
normal limit in the hindbrain (Fig. 1C). In spite of this, the
expressions of cyp26b1 and cyp26c1 are initiated at the correct
anterior-posterior level, and subsequent hindbrain patterning is
unaffected (Fig. 5C,G and data not shown). By stark contrast, in
cyp26a1–/– embryos treated with 5 nM RA, cyp26b1 and cyp26c1
are not expressed, and the entire brain is strongly posteriorized (Fig.
4 and Fig. 5D,H).
cyp26a1 protects against potentially teratogenic
RA precursors
Our findings demonstrate that cyp26a1 protects against the
potentially teratogenic effects of RA. Maternally-derived RA is
present at very low levels in zebrafish eggs and early embryos prior
to the onset of embryonic RA synthesis, and is therefore unlikely to
be a teratogenic risk (Costaridis et al., 1996). However, the levels of
maternally loaded retinal – the immediate precursor of RA – are
higher (9 pmol/egg) (Costaridis et al., 1996; Lampert et al., 2003).
We asked whether Cyp26a1 protects against teratogenicity of RA
precursors. We increased retinal levels in wild-type and cyp26a1–/–
eggs by injecting retinal directly into the yolk of one-cell stage
embryos. Although wild-type embryos tolerate over ten-times the
normal amount of retinal in the yolk (data not shown), cyp26a1–/–
embryos are strongly posteriorized by only a three-times the normal
amount of retinal (27 pmol; Fig. 6). The teratogenic effects of a
small increase in RA precursor in the absence of Cyp26a1
demonstrates that Cyp26a1 may normally play an important role in
protecting the embryo against the potentially teratogenic effects of
maternally derived RA precursors. They also suggest that the RA
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The effects of blocking RA synthesis with DEAB in zebrafish
have been described previously (Begemann et al., 2004; Maves and
Kimmel, 2005). They include the loss of posterior hindbrain
identities (r5-r8, Fig. 4C), expansion of anterior hindbrain identities
(r2-r4), and a dramatic anterior shift of paraxial- and lateral-plate
mesoderm-derived tissues (pronephros and somites; Fig. 4C). In
wild-type (cyp26a1+/+ and cyp26a1+/–) DEAB-treated embryos, this
phenotype is rescued by treatment with between 0.5 and 10 nM RA:
concentrations that are non-teratogenic or weakly teratogenic in
wild-type embryos (Fig. 4E,G,I,K and data not shown). In the
experiments described below, we used 5 nM RA as our ‘rescuing’
concentration. Whereas in wild-type embryos 5 nM RA is nonteratogenic, it strongly posteriorizes cyp26a1–/– embryos, either in
the presence or in the absence of DEAB, causing anterior expansion
of r7-r8 identity (Fig. 4E,F and data not shown) and the loss of all
brain regions anterior to r7: r3 and r5 (marked by krox20; Fig. 4E,F,IL); r4 (marked by hoxb1a; Fig. 4G,H); the cerebellum and posterior
tectum (marked by en3; Fig. 4G-J); the diencephalon and midbrain
(marked by otx2; Fig. 4K,L); and the telencephalon and eyes
[marked by dlx2 (Fig. 4I,J) and by eomes (data not shown)].
Embryos posteriorized in this manner typically exhibited an
accordion-like folding of the anterior neural tube. Exactly the same
effects are observed in cyp26a1–/– embryos treated with 5 nM RA in
the absence of DEAB (data not shown). This phenotype strongly
resembles the effects of 40-fold-higher levels of RA on wild-type
embryos (inset in Fig. 4J), demonstrating that it is the ability of
cyp26a1 to inactivate RA that enables RA-deficient embryos to be
rescued by exogenous RA. Furthermore, these results demonstrate
that cyp26a1 is able to protect embryos from the potentially
teratogenic effects of low concentrations of RA. We did not see a
similar sensitivity to exogenous RA in cyp26b1 and/or cyp26c1 MOinjected embryos.

Fig. 5. Exogenous RA disrupts cyp26b1 and cyp26c1 expression
in cyp26a1–/– embryos but not in wild type. cyp26b1 (A-D) and
cyp26c1 (E-H) expression (blue) is established normally in wild-type
(A,E) and cyp26a1–/– (B,F) embryos at the 6-somite stage (12 hpf).
cyp26b1 and cyp26c1 expression is also established normally in wildtype embryos treated with a sub-teratogenic concentration of RA (5
nM; C,G), but not in cyp26a1–/– embryos treated with 5 nM RA (D,H).
krox20 expression is shown in red.

biosynthetic enzyme Aldh1a2 is unable to buffer changes in the
levels of its substrate. Because retinal is itself derived directly from
dietary vitamin A, it may be expected to fluctuate depending on
maternal diet. These observations emphasize the crucial importance
of a tightly regulated RA-degradative pathway in nervous system
patterning.
DISCUSSION
A gradient-free model for hindbrain patterning by
retinoic acid
A robust model for the mechanism of hindbrain patterning must
explain the following observations: (1) RA is essential for normal
hindbrain development; however, neither the concentration of RA
nor the localization of its synthesis are crucial for this pattern; and
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(2) RA-dependent gene expression occurs in a spatio-temporal
sequence, with anterior RA-responsive genes being expressed earlier
than posterior ones; however, the duration of RA exposure is not
crucial for this temporal sequence (Maves and Kimmel, 2005).
We have identified a crucial role for Cyp26 RA-metabolizing
enzymes in establishing hindbrain pattern, because depleting them
alone and in combination leads to a progressive posteriorization of
the hindbrain. In fully Cyp26-depleted embryos, three RAdependent genes that normally form nested expression domains with
distinct anterior limits (hoxb1a, r3-r4; vhnf1, r4-r5; and hoxd4, r6r7) are all expanded up to the anterior-most hindbrain (Fig. 7A).
Based on the dynamic expression of the cyp26 genes in the
hindbrain and on the effects of depleting embryos of Cyp26 activity,
we propose a gradient-free model for RA-dependent events in
hindbrain patterning, in which RA degradation by Cyp26 enzymes
determines progressively more-posterior limits of RA-dependent
gene expression in a step-wise manner (Fig. 7B). We note that cyp26
genes are expressed similarly, although not identically, in tetrapods,
predicting a similar combinatorial role for Cyp26 enzymes in
mammalian hindbrain development.
In step 1, complete by 9 hpf, the anterior limit of hoxb1b and
hoxb1a – the functional homologs of mammalian HOXA1 and
HOXB1 – are established by the posterior limit of cyp26a1
expression. This event establishes the r3-r4 boundary (Kudoh et al.,
2002), the first morphological boundary in the hindbrain (Moens et
al., 1998). This function can be compensated for by cyp26c1,
because the anterior limit of r4 is strongly affected only in the
absence of both cyp26a1 and cyp26c1. In step 2, complete by 11 hpf,
the anterior limit of the next RA-responsive gene, vhnf1, is
determined by the posterior limit of cyp26c1 expression at the r4-r5
boundary. This function can be partially compensated for by
cyp26b1. In step 3, complete by 12 hpf, the anterior limit of the last
RA-responsive gene, hoxd4, is determined by the posterior limit of
cyp26c1 at the r6-r7 boundary, a function that can also be
compensated for by the overlapping expression of cyp26b1. Some
of the mechanistic underpinnings of this model and its broader
implications are discussed further below.
A similar model was previously proposed based on the
correspondence between cyp26a1 and cyp26c1 expression domains
and boundaries of RA-dependent reporter-gene expression in the
mouse (Sirbu et al., 2005). These authors predicted that cyp26a1
establishes the r2-r3 boundary and that cyp26c1 subsequently
establishes the r4-r5 boundary. Our combinatorial functional
analysis of cyp26 genes confirms this model in the general sense that
Cyp26 activity determines sequential boundaries of RA-responsive
gene expression in the hindbrain. However, our observations
demonstrate a different and broader role for cyp26 genes in
hindbrain patterning, involving all three cyp26 genes functioning to
establish three sequential RA-responsiveness boundaries: r3-r4, r4r5 and r6-r7. We do not observe a function for Cyp26 enzymes at the
r2-r3 boundary: r1-r3 are entirely lost while r4 identity shifts
anteriorly to abut the forming cerebellum.

Fig. 6. cyp26a1 protects against teratogenic
effects of the RA precursor retinal. Wild-type (A)
and cyp26a1–/– (B) embryos injected with 20 pmol
retinal at the one-cell stage. Wild-type embryos are
only mildly affected by approximately triple the normal
levels of retinal, whereas cyp26 mutants are strongly
posteriorized, with hoxd4 expression extending
throughout the brain. Scale bar: 100 m.
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Fig. 7. A model for hindbrain patterning through regulated RA
inactivation by the Cyp26 enzymes. (A) RA-responsive gene
expression in Cyp26-depleted embryos. Embryos depleted of all three
cyp26 genes experience unpatterned RA signaling; as a result, the three
RA-responsive genes examined in this study – hoxb1a (green), vhnf1
(yellow) and hoxd4 (orange) – are expressed throughout the
transformed hindbrain. (B) A ‘gradient free’ model for hindbrain
patterning through regulated RA inactivation. Dynamic patterns of
Cyp26 expression in the hindbrain (blue bars) antagonize RAdependent gene expression by eliminating RA (red bars) first in the
anterior hindbrain (6-9 hpf), then in r2-r4 (9-11 hpf), and then in r2-r6
(11-12 hpf). At each point, sequential RA-responsive genes (colored
bars) are limited to progressively more posterior rhombomeres. At the
same time, Cyp26a1-dependent RA degradation in the trunk
mesoderm suppresses global RA levels (black hammers on right side).
tel: telencephalon; di; diencephalon; mb: midbrain; c: cerebellum.

We find that cyp26a1 and cyp26c1 are both required to establish
the anterior limit of hoxb1a expression at the r3-r4 boundary, and
that all three genes are required to establish the r4-r5 and r6-r7
boundaries. This degree of redundancy is unexpected given the lack
of overlap between the expression domains of the cyp26 genes in the
hindbrain. The posterior limit of cyp26a1 expression lies in the
anterior hindbrain (Dobbs-McAuliffe et al., 2004; Kudoh et al.,
2002; Sirbu et al., 2005), whereas both cyp26b1 and cyp26c1 mark,
sequentially, the r4-r5 and r6-r7 boundaries. However, it is important
to notice that cyp26a1 is also expressed in the anterior trunk
mesoderm near the RA source, where it probably functions to reduce
global RA levels (Emoto et al., 2005; Niederreither et al., 2002). We
propose that the severe posteriorization of Cyp26-depleted embryos
results from the combined effects of depleting segment-restricted
Cyp26 activity within the hindbrain and increasing global RA levels
due to the loss of Cyp26a1 activity in the anterior trunk mesoderm
(Fig. 7B).

Because hindbrain patterning is unaffected in cyp26b1; cyp26c1depleted embryos when cyp26a1 is wild type, we hypothesize that
redundant mechanisms can control boundaries of RA-dependent
gene expression in the hindbrain, but that these mechanisms are
overridden in cyp26a1 mutants in which global RA levels are
elevated. One trivial possibility is that our MOs have not fully
depleted Cyp26b1 and Cyp26c1 activity; however, our validation
experiments with these MOs indicate that they deplete over 95% of
the wild-type gene products. A second possibility is that nonhomogeneous expression of RARs or RXRs in the hindbrain may
modulate RA responsiveness. During the stages when RA is
patterning the zebrafish hindbrain, two receptors – RAR␣a and
RAR␣b – are expressed throughout the hindbrain, but RAR␣b
mRNA levels are higher in the presumptive r5 and r6 whereas
RAR␣a mRNA levels are higher posterior to the presumptive r6-r7
boundary (Hale et al., 2006). Furthermore, RXR␥, a RA co-receptor,
is exclusively expressed posterior to the r6-r7 boundary (Tallafuss
et al., 2006). By increasing the RA response, these nonhomogeneously distributed RARs and RXRs may help to establish
the r4-r5 and r6-r7 boundaries. A third possibility is that spatially
restricted transcription factors repress RA-responsive gene
expression even when ligand and receptor are present. Iro7 (also
known as Irx7 – Zebrafish Information Network) is a TALE
homeodomain protein expressed in the anterior hindbrain that
represses vhnf1 expression anterior to the r4-r5 boundary (Lecaudey
et al., 2004). Other TALE homeodomain proteins have been shown
to repress transcription from retinoid-responsive elements by
binding to RXR retinoid receptors and recruiting general corepressors to the complex (Bartholin et al., 2006). Thus, Iro7 may
compensate for Cyp26b1 and Cyp26c1 by directly suppressing RAresponsive gene expression anterior to the r4-r5 boundary. Finally, a
diffusion gradient of RA from its source in the anterior trunk
mesoderm may compensate for the absence of hindbrain Cyp26
expression. RA can act as a classical morphogen, specifying distinct
rhombomere identities at different threshold concentrations (Dupe and
Lumsden, 2001; Maves and Kimmel, 2005), and an RA gradient may
initiate nested domains of RA-responsive gene expression in the
hindbrain when cyp26b1 and cyp26c1 are depleted. We note that any
or all of the mechanisms we have proposed above (a diffusion
gradient, receptor expression or other transcription factors that
modulate RAR activity) may contribute to hindbrain patterning under
normal circumstances. However, none of these mechanisms are
sufficient to limit RA responsiveness in the hindbrain when all three
Cyp26 enzymes are depleted.
cyp26a1 is required to establish hindbrain pattern
in the absence of a localized source of RA
We have shown that, in the zebrafish, cyp26a1 is essential for the
ability of exogenous RA to rescue embryos in which endogenous RA
synthesis is inhibited. Although 5 nM RA can fully rescue the
hindbrain and anterior trunk patterning defects of wild-type embryos
in which RA synthesis is inhibited with DEAB, in cyp26a1–/– embryos
it causes a strong posteriorization similar to that normally caused by
40 times more RA. From this, we conclude that Cyp26a1 is
responsible for the normal pattern generated in the presence of
otherwise teratogenic amounts of RA.
How does Cyp26a1 protect the embryos from exogenous RA? We
observe that, in embryos treated with 5 nM RA, cyp26a1 expression
expands throughout the epiblast. This expanded expression
presumably eliminates the excess RA and allows the normal onset of
expression of cyp26b1, cyp26c1 and other redundant factors described
above that can modulate RA-responsive gene expression in the
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hindbrain, and the hindbrain develops normally under these
conditions. In cyp26a1 mutants treated with 5 nM RA, the excess RA
is not eliminated, cyp26b1 and cyp26c1 expression is not initiated, and
the entire brain is transformed to posterior hindbrain and/or anterior
spinal cord identity. Unlike in untreated cyp26a1 mutants, cyp26b1
and cyp26c1 cannot compensate for the lack of cyp26a1 because they
are not expressed.
The phenotype of cyp26a1–/– embryos treated with 5 nM RA is
significantly more severe than that of embryos depleted of all three
Cyp26 enzymes in the absence of exogenous RA. In the former, the
entire brain is transformed to an r7 and/or r8 identity whereas, in the
latter, only the hindbrain territory is transformed. This difference
may be because, in untreated embryos, RA simply does not diffuse
as far as the midbrain, so Cyp26 enzymes are not required to
inactivate it there. However, we have noted a surprisingly sharp
anterior limit of RA-responsiveness in Cyp26-depleted embryos that
corresponds with the posterior limit of the presumptive cerebellum.
It is possible that other mechanisms prevent RA signaling anterior
to this boundary. The development of the mid- and fore-brain has
been shown to require active repression of gene expression by
unliganded RARs (Koide et al., 2001), a mechanism that is expected
to be easily destabilized by the presence of RA. It seems likely that
multiple mechanisms exist that protect the mid- and fore-brain from
the teratogenic effects of RA.
Regulation of cyp26 expression
A major outstanding question is how is cyp26 expression normally
regulated in the hindbrain? Kudoh et al. (Kudoh et al., 2002) showed
that the normal posterior limit of cyp26a1 in the hindbrain is
established by signals (FGFs and Wnts) from the margin because, in
embryos treated with antagonists of these pathways, the cyp26a1
boundary is shifted posteriorly. Although cyp26a1 is directly inducible
by RA, its anterior neurectodermal expression arises independently of
RA (Dobbs-McAuliffe et al., 2004; Sirbu et al., 2005) (our work). The
factors that positively regulate cyp26a1 in the anterior neurectoderm
remain to be identified.
We also do not know how cyp26b1 and cyp26c1 expression is
initiated in r2-r4, or what regulates their subsequent expansion into r5
and r6. In general, the mechanisms controlling gene expression in the
anterior rhombomeres are poorly understood in any vertebrate (Moens
and Prince, 2002). Similar to other anterior hindbrain genes, the
initiation of cyp26b1 and cyp26c1 expression is independent of RA,
because both genes are expressed in DEAB-treated embryos. cyp26b1
and cyp26c1 expression is also independent of the prior establishment
of hindbrain boundaries by Cyp26a1, because both genes are
expressed normally in cyp26a1 mutants and in embryos in which
cyp26a1 expression is globally up-regulated by sub-teratogenic
concentrations of RA. The early expression domain of cyp26b1 and
cyp26c1 in r3 and r4 is similar to that of iro7, suggesting that they may
be downstream of, or co-regulated with, iro7 (Lecaudey et al., 2004).
Modern genetic and genomic resources available for the zebrafish will
allow the important mystery of cyp26 regulation to be addressed in the
future.
Implications for the regulation of retinoic acid
during hindbrain patterning
The model we propose for hindbrain patterning through localized
RA inactivation by Cyp26 enzymes (Fig. 7B) accounts for a number
of previously unexplained aspects of hindbrain patterning. First
among these is the observation that embryos depleted of endogenous
RA can be rescued by exogenous RA. This rescue can be achieved
over a 20-fold range of RA concentrations, indicating that RA-
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dependent gene expression is also not strictly concentrationdependent. By generating a stepwise pattern of RA degradation
during hindbrain development, Cyp26 enzymes eliminate the need
for a continuous RA gradient. Secondly, a major tenet of the RA
morphogen model has been that more-posterior RA-responsive
genes, such as the hox-4 genes, are less sensitive to RA than moreanterior ones, such as the hox-1 genes (Gould et al., 1998); however,
this has recently been challenged by the observation that, in the
context of the intact enhancer, the RARE of hoxd4 is no less
sensitive to RA than the RARE of hoxa1 (Nolte et al., 2003).
Furthermore, posterior RA-responsive genes do not require a longer
exposure to RA than anterior ones, as has been proposed (Dupe and
Lumsden, 2001; Sirbu et al., 2005), because identical concentrations
of RA applied shortly before the normal initiation of expression are
sufficient to rescue this expression in RA-depleted embryos,
irrespective of the anterior limit of the RA-responsive gene in
question (Maves and Kimmel, 2005). According to our model, the
anterior limit of hoxb1a, vhfn1 and hoxd4 are determined not by
different RA concentrations or length of exposure of cells to RA, but
simply by the posterior limit of Cyp26 activity at the time of their
expression onset. In its most extreme version, each ‘step’ in the
model is essentially a binary decision in which cells posterior to the
Cyp26 domain experience RA and initiate RA-responsive gene
expression appropriate for that developmental time, while cells
within the Cyp26 domain do not. What determines which RAresponsive genes are available to be expressed at a given time is the
subject of ongoing studies. Recent work has shown that, within a
Hox cluster, the timing of hindbrain expression may be regulated by
the progressive opening of chromatin rather than the local
accumulation of active transacting factors (Chambeyron et al.,
2005).
A RA-dependent patterning mechanism that does not require the
formation of a stable gradient in either space or time is expected to be
robust to environmental fluctuations. RA is a potent teratogen that is
derived from dietary sources of vitamin A, so a robust mechanism for
controlling its activity is particularly important. This control does not
appear to be exerted at the level of RA biosynthesis, because we have
observed that, in the absence of Cyp26a1, even low amounts of
precursor are highly teratogenic. Our step-wise model for hindbrain
patterning by RA is robust in that it tolerates a broad range of
environmental conditions.
Although our model provides robustness to the hindbrainpatterning process and explains how patterning can be established
in the presence of uniform RA, our data does not rule out the
possibility that other mechanisms act redundantly with RA
degradation to pattern the hindbrain under normal circumstances.
Indeed, our observation that hindbrain Cyp26b1 and Cyp26c1
activity is dispensable when global RA levels are kept in check by
Cyp26a1 suggests that such mechanisms are at work. It is possible
that a RA-responsive pre-pattern is established by a transient RAdiffusion gradient, but that Cyp26 enzymes are required to ‘lock in’
this pattern. As with other developmental processes, it is likely that
RA-dependent nervous system patterning events are controlled by
overlapping, redundant mechanisms that modulate RA signaling at
multiple levels. Our work demonstrates that Cyp26-dependent RA
degradation is a crucial component of this complex regulation.
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Note added in proof

Recently, Uehara et al. (Uehara et al., 2006) reported an anterior
expansion of retinoic acid responsiveness in Cyp26a1–/–; Cyp26c1–/–
double mutant mice that is similar to the phenotype we have
observed in cyp26a1–/–; cyp26c1 MO-injected embryos, consistent
with an evolutionarily conserved role for Cyp26 enzymes in shaping
retinoic acid responsiveness in the hindbrain.
Supplementary material
Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/134/1/02706/DC1
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